ELAGOLIX

ELAGOLIX : Antagonist of GNRHR

Structure

Information

  • GNRHR
  • Antagonist
  • up to 100 nM

In Vitro Validations

Uniprot ID: P30968
Target Class: GPCR
Target SubClass: GnRH receptor
Potency: Ki
Potency Value: 0.9 nM
Potency Assay: Competition binding assay
PDB ID for probe-target interaction (3D structure): 7BR3
Target aliases:
Gonadotropin-releasing hormone receptor, GRHR, GNR ...

DOI Reference: 10.1021/jm8006454

Uniprot ID: P30968
Target Class: GPCR
Target SubClass: GnRH receptor
Potency: Kd
Potency Value: 0.54 nM
Potency Assay: Radiolingand binding assay
PDB ID for probe-target interaction (3D structure): 7BR3
Target aliases:
Gonadotropin-releasing hormone receptor, GRHR, GNR ...

DOI Reference: 10.1021/jm8006454

In Cell Validations

In Vivo Data

Off-Target Selectivity Assesments

Potency assay (off target): Elagolix was highly selective at hGnRH-R, its wider receptor selectivity was tested at a concentration of 10 μM in a panel of radioligand binding assays for 100 off-target receptors, ion channels, enzymes, and transporters, and significant activity was not observed (inhibition <50%).
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating
In Model Organisms

SERP Comments:

Elagolix is a clinically validated GnRHR antagonist with strong utility as a chemical probe in systems where human GnRH receptor is expressed and functionally relevant. Elagolix is a highly effective tool for target validation, pharmacological studies, and in vivo hormone suppression. It is best used with careful consideration of species differences, off-target risks, and downstream hormonal effects. Having a structural analogue of Elagolix that is inactive as a negative probe would be very useful in pharmacological studies (see reference DOI: 10.1021/acs.jmedchem.6b01071 for some possible hGnRHR negative probes)

(last updated: 16 May 2025 )